PCOS: An heterogeneous condition with multiple faces for multiple doctors

European Journal of Endocrinology

Volumn 171, Issue 4, 2014, Pages E1-E2

  Bouchard, Philippe ^a   Fauser, Bart C J M ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; SOMATOMEDIN C RECEPTOR; ANDROGEN; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; DENND1A PROTEIN, HUMAN;

AMENORRHEA; BLEEDING; CARDIOVASCULAR DISEASE; DENND1A GENE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; FEMALE; FEMALE INFERTILITY; GENE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PHENOTYPE; WEIGHT GAIN; GENETICS; LITERATURE; METABOLISM; PATIENT CARE; PRACTICE GUIDELINE; RISK FACTOR;

ANDROGENS; CARDIOVASCULAR DISEASES; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; FEMALE; HUMANS; INFERTILITY, FEMALE; PATIENT CARE TEAM; POLYCYSTIC OVARY SYNDROME; PRACTICE GUIDELINES AS TOPIC; REVIEW LITERATURE AS TOPIC; RISK FACTORS;

EID: 84907187329     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0429     Document Type: Editorial

References (15)

1. Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R, Pfeifer M, Pignatelli D & Pugeat M, B O Yildiz on behalf of the ESE PCOS Special Interest Group. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. European Journal of Endocrinology 2014 171 P1-P29. (doi:10.1530/EJE-14-0253)
2. Stein IF & Leventhal ML. Amenorrhoea associated with bilateral polycystic ovaries. American Journal of Obstetrics and Gynecology 1935 29 181-191.
3. Azziz R, Dumesic DA & Goodarzi MO. Polycystic ovary syndrome: an ancient disorder? Fertility and Sterility 2011 95 1544-1548. (doi:10.1016/j.fertnstert.2010.09.032)
4. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 2004 81 19-25.
5. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004 19 41-47. (doi:10.1093/humrep/deh098)
6. NIH Evidence based methodology Workshop on Polycystic Ovary Syndrome December 3-5 2012. https://prevention.nih.gov/docs/programs/pcos/finelreport.pdf.
7. Dunaif A & Fauser BCJM. Renaming PCOS a two state position. Journal of Clinical Endocrinology and Metabolism 2013 98 4325-4328. (doi:10.1210/jc.2013-2040)
8. Fauser BC & Bouchard P. Uncertainty remains in women with PCOS regarding the increased incidence of cardiovascular disease later in life, despite the indisputable presence of multiple cardiovascular risk factors at a young age. Journal of Clinical Endocrinology and Metabolism 2011 96 3675-3677. (doi:10.1210/jc.2011-2935)
9. Legro RS, Driscoll D, Strauss JF III, Fox J & Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. PNAS 1998 95 14956-14960. (doi:10.1073/pnas.95.25.14956)
10. McAllister JM, Modi B, Miller BA, Biegler J, Bruggeman R, Legro RS & Strauss JF III. Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype. PNAS 2014 111 E1519-E1527. (doi:10.1073/pnas.1400574111)
11. Richardson MC, Guo M, Fauser BC & Macklon NS. Environmental and developmental origins of ovarian reserve. Human Reproduction Update 2014 20 353-369. (doi:10.1093/humupd/dmt057)
12. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM & Roth J. The syndromes of insulin resistance and acanthosis nigricans. Insulinreceptor disorders in man. New England Journal of Medicine 1976 294 739-745. (doi:10.1056/NEJM197604012941401)
13. Lungu AO, Zadeh ES, Goodling A, Cochran E & Gorden P. Insulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism 2012 97 563-567. (doi:10.1210/jc.2011-1896)
14. Shi Y, Zhao H, Shi Y, Cao Y, Yang D, Li Z, Zhang B, Liang X, Li T, Chen J et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nature Genetics 2012 44 1020-1025. (doi:10.1038/ng.2384)
15. Louwers YV, Stolk L, Uitterlinden AG & Laven JS. Cross-ethnic metaanalysis of genetic variants for polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2013 98 E2006-E2012. (doi:10.1210/jc.2013-2495)